Price and states served both move. Read them off the seller's own site before you enroll.How our reviews work →

Claya vs MadeMed

MadeMed costs $80 less a month, and both sell semaglutide and tirzepatide.

Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more

By Ruth Calder · Enforcement Editor
Editorially reviewed & fact-checked against primary sources · How we verify contentLast reviewed
Claya logo

Claya

6.6
★★★☆☆3.3/5

Best for: compounded semaglutide at $299/month

Visit Claya →
VS
MadeMed logo

MadeMed

6.5
★★★☆☆3.3/5

Best for: compounded semaglutide at $239/month

Visit MadeMed →

If you are choosing between Claya and MadeMed, the first difference is cost: MadeMed is $80 a month cheaper at the entry price. Both prescribe semaglutide and tirzepatide, so moving from one to the other would not change your drug. Claya leads our six-part score, 6.6 to 6.5.

Claya vs MadeMed price

MadeMed is the cheaper way in: $219 a month on a prepaid plan against $299 a month at Claya. That is $80 less each month (27% lower), or about $960 over a year of treatment.

MadeMed's figure is a monthly average of a plan billed for several months at once, so the first charge is larger than the number shown.

Drug by drug: Semaglutide is cheaper at MadeMed ($219 a month on a prepaid plan vs $299 a month); tirzepatide costs the same at both, $299 a month.

Medications and formats

Both sell semaglutide and tirzepatide.

On format they match: each offers compounded injections and an oral option.

Where each one treats patients

Neither Claya nor MadeMed publishes the states it serves, so enter your state at the very start of each sign-up.

Pricing

Claya

First month introductoryCompounded
$179/mo
semaglutide
Refill (locked rate)Compounded
$299/mo
semaglutide
Oral tablet (first month)Compounded · oral
$279/mo
semaglutide
First month introductoryCompounded
$279/mo
tirzepatide
Refill (locked rate)Compounded
$299/mo
tirzepatide
Oral tablet (first month)Compounded · oral
$379/mo
tirzepatide

MadeMed

Injectable — Starting (billed quarterly, flat at every dose)Compounded
$239/mo
semaglutide

Quarterly plan $239/mo (billed $717/3mo); 6-month plan drops to $199/mo (the site's 'From $199/mo'). Includes L-Carnitine; 2-month supplies.

Injectable — Starting (billed quarterly, flat at every dose)Compounded
$399/mo
tirzepatide

Quarterly $399/mo (billed $1,197/3mo); 6-month $369/mo.

Sublingual tablet — Starting (billed quarterly)Compounded · oral
$219/mo
semaglutide

Quarterly $219/mo (billed $657/3mo); 6-month $179/mo. Includes B6.

Sublingual tablet — Starting (billed quarterly)Compounded · oral
$299/mo
tirzepatide

Quarterly $299/mo (billed $897/3mo); 6-month $279/mo.

What each price covers

Claya's price also covers the medication itself and shipping, which MadeMed does not claim.

Claya is silent on the clinician visit, lab work and coaching.

MadeMed does not say what its price includes.

That matters most for the drug: unless MadeMed confirms otherwise, budget for medication on top of its listed price.

Claya

Covered by the monthly price

Medication

In the price

Clinician visits

Not stated

Shipping

In the price

Lab work

Not stated

Coaching

Not stated

MadeMed

Inclusions not disclosed.

Where each one scores higher

Overall, Claya scores 6.6 and MadeMed 6.5 out of 10.

Claya is stronger on value (3.7 vs 3.1).

MadeMed is stronger on support (5.0 vs 4.5).

Effectiveness, user experience, trust & safety and accessibility are within half a point.

How we score

Claya

6.6/10

Overall

MadeMed

6.5/10

Value25%

3.7A
vs
B
3.1

Effectiveness25%

10.0A
vs
B
10.0

User Experience15%

8.0A
vs
B
8.0

Trust & Safety15%

6.5A
vs
B
6.5

Accessibility10%

5.0A
vs
B
5.0

Support10%

4.5A
vs
B
5.0

FDA warning letters

Neither Claya nor MadeMed has an FDA warning letter on record with us.

Features & Coverage

FeatureClayaMadeMed
Starting Price$299/mo✓$219/mo prepaid
Features✓7 features6 features
States AvailableNot disclosedNot disclosed
Compounded✓ Yes✓ Yes
Brand Name——
FSA/HSA Accepted——
FDA Warning LettersNoneNone

About Claya

Claya lists injectable semaglutide at $179 for the first month, after which refills lock at $299/month. It sells compounded semaglutide and tirzepatide in both injectable and oral-tablet form, a wider format range than most competitors. The site publicly names its clinicians and its two compounding pharmacy partners, and includes a weight-loss money-back guarantee and free expedited shipping.

Read our full Claya review →

About MadeMed

Nothing is priced in public at MadeMed; the number waits inside the product pages or the checkout. Its catalog runs to four distinct products, compounded semaglutide and compounded tirzepatide, each offered as an injection or by mouth, so patients who dislike needles get more choice here than most rivals allow. A LegitScript certification badge is displayed, and unlike chat-only competitors it publishes a phone line for support.

Read our full MadeMed review →

Pros & Cons

Claya

What we like

  • Shows its price before the medical questionnaire, so you can compare it without handing over health information
  • The monthly price includes the medication and shipping
  • We found no FDA warning letters issued to Claya

Watch-outs

  • Semaglutide costs $299 a month, 63% above the $184 median for compounded semaglutide across the sellers we compare
  • Tirzepatide costs $299 a month, 20% above the $250 median for compounded tirzepatide across the sellers we compare
  • Confirm it serves your state before you start the intake
  • Ask which pharmacy fills the prescription before you pay, so you can check its license
  • Its semaglutide and tirzepatide are compounded rather than FDA-approved, so they have not been reviewed by the agency for safety, effectiveness or manufacturing quality

MadeMed

What we like

  • Shows its price before the medical questionnaire, so you can compare it without handing over health information
  • We found no FDA warning letters issued to MadeMed

Watch-outs

  • Semaglutide costs $239 a month, 30% above the $184 median for compounded semaglutide across the sellers we compare
  • Tirzepatide costs $399 a month, 60% above the $250 median for compounded tirzepatide across the sellers we compare
  • Confirm it serves your state before you start the intake
  • Ask which pharmacy fills the prescription before you pay, so you can check its license
  • Its semaglutide and tirzepatide are compounded rather than FDA-approved, so they have not been reviewed by the agency for safety, effectiveness or manufacturing quality

Our Verdict

Winner: Claya

Claya wins this one, 6.6 to 6.5, above all for compounded semaglutide at $299/month. MadeMed undercuts it by $80 a month, so if the monthly bill is what decides it, MadeMed is the pick. MadeMed fits better if compounded semaglutide at $239/month is your priority.

Choose Claya if…

You want compounded semaglutide at $299/month and an opening price near $299 a month.

Choose MadeMed if…

You want compounded semaglutide at $239/month and an opening price near $219 a month.

Ready to start? GLP-1 providers we have vetted

Telehealth providers, vetted by us, prescribing GLP-1 online.

Vetted by our editors · no insurance required

Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more

5.9

Wellorithm

Compounded semaglutide at $247/month

6.6

Willow

Seeing what it charges before you answer any medical questions

6.5

Sesame Care

Oral orforglipron alongside the injectables

Claya vs MadeMed: FAQ

MadeMed. It starts at $219 a month on a prepaid plan; Claya starts at $299 a month, $80 more per month.
Yes, both sell semaglutide and tirzepatide.
Claya does not publish where it ships; MadeMed does not publish where it ships. Confirm your state before paying.
Only Claya includes the medication itself and shipping.
Claya has none. MadeMed has none.
No. Neither Claya nor MadeMed pays us anything.

Or see the full category ranking.